These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11098145)

  • 1. Highly increased plasma concentrations of the nicked form of beta(2) glycoprotein I in patients with leukemia and with lupus anticoagulant: measurement with a monoclonal antibody specific for a nicked form of domain V.
    Itoh Y; Inuzuka K; Kohno I; Wada H; Shiku H; Ohkura N; Kato H
    J Biochem; 2000 Dec; 128(6):1017-24. PubMed ID: 11098145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of 'antiphospholipid' antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding beta(2)-glycoprotein I and prothrombin.
    Sheng Y; Hanly JG; Reddel SW; Kouts S; Guerin J; Koike T; Ichikawa K; Sturgess A; Krilis SA
    Clin Exp Immunol; 2001 Jun; 124(3):502-8. PubMed ID: 11472415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmin can reduce the function of human beta2 glycoprotein I by cleaving domain V into a nicked form.
    Ohkura N; Hagihara Y; Yoshimura T; Goto Y; Kato H
    Blood; 1998 Jun; 91(11):4173-9. PubMed ID: 9596664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolytic cleavage of beta(2)-glycoprotein I: reduction of antigenicity and the structural relationship.
    Matsuura E; Inagaki J; Kasahara H; Yamamoto D; Atsumi T; Kobayashi K; Kaihara K; Zhao D; Ichikawa K; Tsutsumi A; Yasuda T; Triplett DA; Koike T
    Int Immunol; 2000 Aug; 12(8):1183-92. PubMed ID: 10917893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicked beta2-glycoprotein I: a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis.
    Yasuda S; Atsumi T; Ieko M; Matsuura E; Kobayashi K; Inagaki J; Kato H; Tanaka H; Yamakado M; Akino M; Saitou H; Amasaki Y; Jodo S; Amengual O; Koike T
    Blood; 2004 May; 103(10):3766-72. PubMed ID: 14726399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of dilute Russell's viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids.
    Pengo V; Balestrieri G; Tincani A; Spatola L; Biasiolo A; Brocco T
    Thromb Haemost; 1997 Jan; 77(1):123-6. PubMed ID: 9031461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/beta2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies--Co-existence of these antibodies enhances ADP-induced platelet activation in vitro.
    Nojima J; Kuratsune H; Suehisa E; Kitani T; Iwatani Y; Kanakura Y
    Thromb Haemost; 2004 May; 91(5):967-76. PubMed ID: 15116258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.
    Arnout J; Meijer P; Vermylen J
    Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus anticoagulant (LA) testing: performance of clinical laboratories assessed by a national survey using lyophilized affinity-purified immunoglobulin with LA activity.
    Tripodi A; Biasiolo A; Chantarangkul V; Pengo V
    Clin Chem; 2003 Oct; 49(10):1608-14. PubMed ID: 14500585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lupus anticoagulant activity is frequently dependent on the presence of beta 2-glycoprotein I.
    Oosting JD; Derksen RH; Entjes HT; Bouma BN; de Groot PG
    Thromb Haemost; 1992 May; 67(5):499-502. PubMed ID: 1519207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A two-step coagulation test to identify antibeta-glycoprotein I lupus anticoagulants.
    Pengo V; Biasiolo A; Pegoraro C; Iliceto S
    J Thromb Haemost; 2004 May; 2(5):702-7. PubMed ID: 15099274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A functional coagulation test to identify anti-beta2-glycoprotein I dependent lupus anticoagulants.
    Devreese KM
    Thromb Res; 2007; 119(6):753-9. PubMed ID: 16842842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Alessandri C; Bombardieri M; Di Prospero L; Conigliaro P; Conti F; Labbadia G; Misasi R; Sorice M; Valesini G
    Clin Exp Immunol; 2005 Apr; 140(1):173-80. PubMed ID: 15762889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity.
    Hunt JE; Simpson RJ; Krilis SA
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2141-5. PubMed ID: 8460120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ellagic acid/phospholipid-induced coagulation and dextran sulfate-induced fibrinolytic activities in beta 2-glycoprotein I-depleted plasma.
    Shiozaki A; Niiya K; Higuchi F; Tashiro S; Arai T; Izumi R; Sakuragawa N
    Thromb Res; 1994 Oct; 76(2):199-210. PubMed ID: 7863469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta2-glycoprotein I is proteolytically cleaved in vivo upon activation of fibrinolysis.
    Horbach DA; van Oort E; Lisman T; Meijers JC; Derksen RH; de Groot PG
    Thromb Haemost; 1999 Jan; 81(1):87-95. PubMed ID: 10348717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and pathogenic role of anti-beta2-glycoprotein I single-chain Fv domains: induction of experimental antiphospholipid syndrome.
    Blank M; Waisman A; Mozes E; Koike T; Shoenfeld Y
    Int Immunol; 1999 Dec; 11(12):1917-26. PubMed ID: 10590257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.